Skip to content

FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers

Far Field Sensing Test Study in Patients With Implanted Cardiac Dual Chamber Pacemakers

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00196144
Enrollment
207
Registered
2005-09-20
Start date
2002-07-31
Completion date
2004-04-30
Last updated
2007-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

The purpose of this study is to evaluate the effect of individual adjustment of the postventricular atrial blanking period in avoiding inappropriate mode switch of dual chamber pacemakers.

Detailed description

Far-field R-wave sensing (FFS) in the atrial channel of dual chamber pacemakers is a relevant source for inappropriate mode switch from the DDD mode to the DDI or VDI mode. Inappropriate loss of atrioventricular synchrony due to false positive mode switch is hemodynamically disadvantageous, may induce atrial tachyarrhythmias, can lead to pacemaker syndrome, and impairs the reliability of pacemaker Holter data. The aim of the study is to determine whether individual adjustment of the postventricular atrial blanking period (PVAB) based on an additional test is effective in avoiding inappropriate mode switch due to FFS when compared to standard programming of the PVAB

Interventions

DEVICEIndividualized Programming of PVAB

Performance of a test to detect far-field R-wave sensing

DEVICENominal PVAB

nominal pacemaker settings

Sponsors

Deutsches Herzzentrum Muenchen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication for dual chamber pacing * Implantation of an Identity DR pacemaker (St. Jude Medical) * Bipolar atrial pacing electrode

Exclusion criteria

* Heart failure NYHA III and IV * Unstable angina pectoris * Indication for the implantation of an ICD * Cardiac surgery within previous 6 months * Cardiac surgery planed for the next 3 months

Design outcomes

Primary

MeasureTime frame
Incidence of inappropriate mode switch due to far field R-wave sensing3 months

Secondary

MeasureTime frame
Incidence of inappropriate mode switch due to far field R-wave sensing in relation to the lead position3 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026